Previous close | 59.99 |
Open | 62.41 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 62.17 - 62.41 |
52-week range | 43.31 - 65.36 |
Volume | |
Avg. volume | 26 |
Market cap | N/A |
Beta (5Y monthly) | 2.06 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced that management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference. The presentation is scheduled to begin at 3:45 p.m. Eastern Time on Tuesday, April 9, 2024. A link to the live audio webcast, as well as a replay of this event, will be available on the Company’s website under the
Enovis Corporation (NYSE:ENOV) Q4 2023 Earnings Call Transcript February 22, 2024 Enovis Corporation beats earnings expectations. Reported EPS is $0.79, expectations were $0.76. Enovis Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Enovis […]